AccessClosure launches Mynx Cadence Vascular Closure Device AccessClosure side effects.

AccessClosure launches Mynx Cadence Vascular Closure Device AccessClosure, Inc side effects ., the U.S. Market leader in extravascular closure gadgets, today the launch of its next era product announced, the Mynx Cadence Vascular Closure Device . ‘We are really excited about the launch of the Mynx Cadence,’ stated Gregory D. Casciaro, President and CEO of AccessClosure.’ Three design adjustments on the new Mynx Cadence gadget make it much easier and more constant to deploy.’ The Mynx Vascular Closure Gadget utilizes a conformable, water-soluble polyethylene glycol sealant to seal the femoral artery, which dissolves within thirty days, leaving nothing at all behind but a healed artery.